Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 157 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Follow-Up Questions
What is the price performance of CBUS stock?
The current price of CBUS is $1.45, it has increased 7.81% in the last trading day.
What are the primary business themes or industries for Cibus Inc?
Cibus Inc belongs to Biotechnology industry and the sector is Health Care
What is Cibus Inc market cap?
Cibus Inc's current market cap is $78.9M
Is Cibus Inc a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for Cibus Inc, including 2 strong buy, 6 buy, 2 hold, 0 sell, and 2 strong sell
